Several advisors argue that the shorter time frame is needed to market the product before LOGO the MEDIC is released. Worthwhile profits can only be reaped if most of the hospital market is captured before LOGO's release.
Opponents of this proposal note that a well-tested product is superior to an expediently-produced one. Myopic testing risks failing to detect falws in the product.
The company is awaiting your executive decision. What will it be?